Company intelligence
Boehringer Ingelheim
Pharmaceutical Manufacturing
Ingelheim am Rhein, DE
10,001+ employees
43 public signals
About Boehringer Ingelheim
Our people are our strength. And together with over 54,000 colleagues, we're creating the next breakthrough in the world of healthcare and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint
Verified activity
Signals from Boehringer Ingelheim
43 published signals
Products & Services
Boehringer Ingelheim offers BI-7828, a potent MDM2-p53 antagonist that reactivates p53 signaling in TP53 wild-type tumors.
Reported by Florian Montel
Products & Services
Boehringer Ingelheim is inviting experts to propose bold concepts for an autonomous small-molecule synthesis platform encompassing the complete Make phase from reagent handling to delivery of purified compounds.
Reported by Florian Montel
Products & Services
Boehringer Ingelheim offers BI-7828, a potent MDM2-p53 antagonist that reactivates p53 signaling in TP53 wild-type tumors.
Reported by Florian Montel